NASDAQ:KPTI | Free Cash Flow | Karyopharm Therapeutics Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2011-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$22.73M
2025-12-31-$11.83M$0.00-$11.83M
2025-03-31-$38.98M$0.00-$38.98M
2024-12-31-$25.81M-$53,000.00-$25.86M
2024-03-31-$43.73M$195,000.00-$43.92M
2023-12-31-$18.59M$0.00-$18.59M
2023-03-31-$18.91M$0.00-$18.91M
2022-12-31-$26.84M$0.00-$26.84M
2022-03-31-$59.2M$79,000.00-$59.28M
2021-12-31$25.48M$207,000.00$25.27M65.26%
2021-03-31-$52.89M$0.00-$52.89M
2020-12-31-$30.63M$119,000.00-$30.75M
2020-03-31-$45.01M$10,000.00-$45.02M
2019-12-31-$39.49M$50,000.00-$39.54M
2019-03-31-$66.62M$49,000.00-$66.67M
2018-12-31-$48.17M$1.09M-$49.27M
2018-03-31-$34.65M$382,000.00-$35.03M
2017-12-31-$5.54M$55,000.00-$5.59M
2017-03-31-$24.71M
2016-12-31-$20M$25,000.00-$20.02M
2016-03-31-$23.17M$39,000.00-$23.2M
2015-12-31-$20.38M$505,000.00-$20.88M
2015-03-31-$20.23M$178,000.00-$20.4M
2014-12-31-$12.77M$99,000.00-$12.87M
2014-03-31-$10.57M$125,000.00-$10.69M
2013-12-31-$10.08M$32,000.00-$10.11M
2013-03-31-$5.16M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$75.37M$0.00-$75.37M
2024-12-31-$127.49M$142,000.00-$127.63M
2023-12-31-$92.72M$0.00-$92.72M
2022-12-31-$149.55M$118,000.00-$149.67M
2021-12-31-$107.12M$212,000.00-$107.33M
2020-12-31-$160.23M$145,000.00-$160.38M
2019-12-31-$190.82M$206,000.00-$191.03M
2018-12-31-$159.12M$2.36M-$161.48M
2017-12-31-$73.72M$62,000.00-$73.78M
2016-12-31-$84.39M$70,000.00-$84.46M
2015-12-31-$94.03M$1.42M-$95.45M
2014-12-31-$51.45M$2.83M-$54.28M
2013-12-31-$30.29M$57,000.00-$30.35M
2012-12-31-$15.51M$121,000.00-$15.63M
2011-12-31-$8.55M$376,000.00-$8.93M